Cargando…

Fecal Microbial Transplantation and Its Potential Application in Cardiometabolic Syndrome

Newly revealed links between inflammation, obesity, and cardiometabolic syndrome have created opportunities to try previously unexplored therapeutic modalities in these common and life-risking disorders. One potential modulator of these complex disorders is the gut microbiome, which was described in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leshem, Avner, Horesh, Nir, Elinav, Eran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587678/ https://www.ncbi.nlm.nih.gov/pubmed/31258528 http://dx.doi.org/10.3389/fimmu.2019.01341

Ejemplares similares

Trimming Trem2 and possible impacts on the metabolic syndrome
por: Shapiro, Hagit, et al.
Publicado: (2022)

The Gut Microbiome and Individual-Specific Responses to Diet
por: Leshem, Avner, et al.
Publicado: (2020)

Time‐limited diets and the gut microbiota in cardiometabolic disease
por: Ratiner, Karina, et al.
Publicado: (2022)

Clusterin and Its Role in Insulin Resistance and the Cardiometabolic Syndrome
por: Wittwer, Jennifer, et al.
Publicado: (2021)

Fecal microbial transplantation
por: Srinivasan, Indu, et al.
Publicado: (2017)

Fecal Microbiota Transplantation: A Potential Tool for Treatment of Human Female Reproductive Tract Diseases
por: Quaranta, Gianluca, et al.
Publicado: (2019)

Clinical efficacy of fecal microbial transplantation treatment in adults with moderate‐to‐severe atopic dermatitis
por: Mashiah, Jacob, et al.
Publicado: (2021)

Smoking-induced microbial dysbiosis in health and disease
por: Shapiro, Hagit, et al.
Publicado: (2022)

The Evolving Landscape of Fecal Microbial Transplantation
por: Shao, Tihong, et al.
Publicado: (2023)

Case report: Fecal microbiota transplantation in refractory ankylosing spondylitis
por: Wang, Lei, et al.
Publicado: (2023)

Chronobiomics: The Biological Clock as a New Principle in Host–Microbial Interactions
por: Thaiss, Christoph A., et al.
Publicado: (2015)

Fecal microbiota transplantation for irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials
por: Wang, Mancai, et al.
Publicado: (2023)

Distinct fecal microbial signatures are linked to sex and chronic immune activation in pediatric HIV infection
por: Rosel-Pech, Cecilia, et al.
Publicado: (2023)

Fecal Metabolomics and Potential Biomarkers for Systemic Lupus Erythematosus
por: Zhang, Qiong, et al.
Publicado: (2019)

Immune Responses to Broad-Spectrum Antibiotic Treatment and Fecal Microbiota Transplantation in Mice
por: Ekmekciu, Ira, et al.
Publicado: (2017)

Fecal microbiota transplantation treatment of autoimmune-mediated type 1 diabetes mellitus
por: He, Lina, et al.
Publicado: (2022)

Antitumor effects of fecal microbiota transplantation: Implications for microbiome modulation in cancer treatment
por: Xu, Hui, et al.
Publicado: (2022)

Gut bacteriophage dynamics during fecal microbial transplantation in subjects with metabolic syndrome
por: Manrique, Pilar, et al.
Publicado: (2021)

An Immunologic Compatibility Testing Was Not Useful for Donor Selection in Fecal Microbiota Transplantation for Ulcerative Colitis
por: Ponce-Alonso, Manuel, et al.
Publicado: (2021)

Potential Application of T-Follicular Regulatory Cell Therapy in Transplantation
por: Dudreuilh, Caroline, et al.
Publicado: (2021)

Application of fecal microbial transplantation in hepatic encephalopathy after transjugular intrahepatic portosystemic shunt
por: Li, Jun, et al.
Publicado: (2022)

Fecal Microbiota Transplantation Modulates Renal Phenotype in the Humanized Mouse Model of IgA Nephropathy
por: Lauriero, Gabriella, et al.
Publicado: (2021)

Research trends on clinical fecal microbiota transplantation: A biliometric analysis from 2001 to 2021
por: Li, Yu, et al.
Publicado: (2022)

Are There Potential Applications of Fecal Microbiota Transplantation beyond Intestinal Disorders?
por: Zhou, Youlian, et al.
Publicado: (2019)

The cardiometabolic conditions of psoriatic disease
por: Toussirot, Eric, et al.
Publicado: (2022)

Fecal Microbiota Transplantation Reshapes the Physiological Function of the Intestine in Antibiotic-Treated Specific Pathogen-Free Birds
por: Li, Peng, et al.
Publicado: (2022)

Whole intestinal microbiota transplantation is more effective than fecal microbiota transplantation in reducing the susceptibility of DSS-induced germ-free mice colitis
por: Yang, Yapeng, et al.
Publicado: (2023)

Can Fecal Microbial Transplant Effectively Treat Crohn's Disease?
por: Dai, Cong, et al.
Publicado: (2015)

Fecal microbial transplant for the treatment of pediatric inflammatory bowel disease
por: Wang, Alice Yuxin, et al.
Publicado: (2016)

Use of Fecal Microbial Transplantation for Immune Checkpoint Inhibitor Colitis
por: Fasanello, Micaela K., et al.
Publicado: (2020)

The use of donor-derived veto cells in hematopoietic stem cell transplantation
por: Ophir, Eran, et al.
Publicado: (2012)

Fecal Microbiota Transplantation Donor and Dietary Fiber Intervention Collectively Contribute to Gut Health in a Mouse Model
por: Zhong, Yifan, et al.
Publicado: (2022)

Human Fecal Microbiota Transplantation Reduces the Susceptibility to Dextran Sulfate Sodium-Induced Germ-Free Mouse Colitis
por: Yang, Yapeng, et al.
Publicado: (2022)

Safety and efficacy of fecal microbiota transplantation for autoimmune diseases and autoinflammatory diseases: A systematic review and meta-analysis
por: Zeng, Liuting, et al.
Publicado: (2022)

Fecal microbiota transplantation and its potential therapeutic uses in gastrointestinal disorders
por: Heath, Ryan D., et al.
Publicado: (2018)

Altered Fecal Metabolomics and Potential Biomarkers of Psoriatic Arthritis Differing From Rheumatoid Arthritis
por: Wang, Nan, et al.
Publicado: (2022)

The fecal microbiota of healthy donor horses and geriatric recipients undergoing fecal microbial transplantation for the treatment of diarrhea
por: McKinney, Caroline A., et al.
Publicado: (2020)

Treating Steroid Refractory Intestinal Acute Graft-vs.-Host Disease With Fecal Microbiota Transplantation: A Pilot Study
por: Qi, Xiaofei, et al.
Publicado: (2018)

Application of density gradient for the isolation of the fecal microbial stool component and the potential use thereof
por: Hevia, Arancha, et al.
Publicado: (2015)

The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation
por: Mazzawi, Tarek, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hm2gvb3fngun7m1d5l4lqqtdj9